https://www.selleckchem.com/pr....oducts/Benserazide-h
05) and in the physical component score (PCS) (p0.05). These differences were maintained until 3 months of follow-up in the case of the PCS and until the end of follow-up in the case of the PF (p0.05). Patients with a SVA50mm showed a slower recovery of their quality of life after VP for OVCF, but without significant differences with respect to pain or disability, when compared with patients with SVA50mm. 50mm showed a slower recovery of their quality of life after VP for OVCF, but without sig
Like
Comment
Share
